Three papers recently published in Nature Medicine provide the most detailed analyses of fetal midbrain grafts in patients with Parkinson's disease. Some of the results are surprising and suggest a new wave of questions aimed at both the value of cell therapy and the nature of the disease itself.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.neuron.2008.05.016 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!